Unknown

Dataset Information

Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer.


ABSTRACT:

Objectives

This study sought to evaluate the contribution of microvascular functional rarefaction and changes in vascular mechanical properties to the development of hypertension and secondary ventricular remodeling that occurs with anti-vascular endothelial growth factor (VEGF) therapy.

Background

Hypertension is a common side effect of VEGF inhibitors used in cancer medicine.

Methods

Mice were treated for 5 weeks with an anti-murine VEGF-A monoclonal antibody, antibody plus ramipril, or sham treatment. Microvascular blood flow (MBF) and blood volume (MBV) were quantified by contrast-enhanced ultrasound in skeletal muscle, left ventricle (LV), and kidney. Echocardiography and invasive hemodynamics were used to assess ventricular function, dimensions and vascular mech

SUBMITTER: Belcik JT 

PROVIDER: S-EPMC3963486 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature